PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B

PRMT6, a type I arginine methyltransferase, di-methylates the arginine residues of both histones and non-histones asymmetrically. Increasing evidence indicates that PRMT6 plays a tumor mediator involved in human malignancies. Here, we aim to uncover the essential role and underlying mechanisms of PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji, Xiao, Zongyu, Li, Peng, Wu, Chunwang, Li, Yan, Wang, Qing, Chen, Yanming, Zhou, Honglong, Li, Zhi, Wang, Zhaotao, Lan, Qing, Wang, Yezhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063447/
https://www.ncbi.nlm.nih.gov/pubmed/36792756
http://dx.doi.org/10.1038/s41388-023-02624-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063447/
https://www.ncbi.nlm.nih.gov/pubmed/36792756
http://dx.doi.org/10.1038/s41388-023-02624-7

Ejemplares similares